Doane Chilcoat

Doane Chilcoat has a long and varied work experience. Doane began their career in 1999 as an Associate Principal at McKinsey & Company. In 2006, they moved to Replidyne as a Senior Director. In 2010, they became the President and CEO of Cobax Biopharma. In 2011, they joined DuPont Pioneer as the Director of Applied Technology Systems, where they were responsible for a 450-person R&D group with 6 global locations. In 2014, they became the Chief Technology Officer of the State of Iowa and Chair of the Iowa Innovation Council at the Iowa Economic Development Authority, as well as the Chair of the Science and Industry Advisory Committee at Genome Canada. In 2017, they joined Corteva Agriscience as the Leader of Applied Science and Technology, where they were responsible for a large segment of Corteva’s R&D organization and led the establishment of a CLIA-certified Covid testing lab. Most recently, in 2021, they joined Design Therapeutics as the Vice President of Technology and Research Operations.

Doane Chilcoat received a BA in Biology from Grinnell College in 1993 and a Ph.D. in Molecular Genetics and Cell Biology from the University of Chicago in 1999.